Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/20/2025

IV Potassium Correction for Severe Pediatric Hypokalemia

Introduction to Treatment

  • For a child with severe hypokalemia, the American Academy of Pediatrics recommends administering IV potassium chloride at 0.25 mmol/kg over 30 minutes, followed by continuous infusion at 0.25 mEq/kg/hour with continuous cardiac monitoring until potassium normalizes above 2.5 mEq/L, then transition to oral replacement 1, 2

Immediate Assessment and Pre-Treatment Checks

  • Before initiating potassium replacement, verify adequate urine output (≥0.5 mL/kg/hour) to confirm renal function, as recommended by the American Diabetes Association 3, 2
  • Check and correct magnesium levels first, as hypomagnesemia is the most common reason for refractory hypokalemia, targeting magnesium >0.6 mmol/L, according to the British Medical Journal 1, 4, 2

Initial IV Replacement Protocol

  • Administer 0.25 mmol/kg (0.25 mEq/kg) potassium over 30 minutes, as recommended by the British Medical Journal 1
  • Infuse over 30 minutes via peripheral IV, with a concentration not exceeding 40 mEq/L, as recommended by the British Medical Journal 1

Monitoring Protocol

  • Recheck serum potassium within 1-2 hours after initial bolus to assess response and avoid overcorrection, as recommended by the American Academy of Pediatrics 4, 2
  • Continue cardiac monitoring continuously, watching for peaked T waves, widened QRS, or arrhythmias indicating overcorrection, as recommended by the American Heart Association 2

Critical Concurrent Interventions

  • If magnesium <0.6 mmol/L, administer magnesium sulfate 25-50 mg/kg IV over 2-4 hours, as recommended by the American Academy of Pediatrics 5
  • Hypomagnesemia makes hypokalemia resistant to correction, regardless of how much potassium is given, according to the British Medical Journal 1, 4, 2

Target Potassium Range

  • Aim for serum potassium 4.0-5.0 mEq/L, as recommended by the American Academy of Pediatrics, to minimize cardiac risk in all patients 4, 2

IV Potassium Replacement for Severe Pediatric Hypokalemia

Special Considerations for Pediatric Patients

  • In children with diabetic ketoacidosis, adding 20-40 mEq/L potassium to IV fluids once K+ falls below 5.5 mEq/L with adequate urine output is recommended by Clinical Nutrition 6

Potassium Chloride Solution Concentration and Administration Guidelines

Calculation and Concentration

  • A solution containing 150 mg potassium chloride per 1 mL equals 2 mEq/mL, which represents a highly concentrated potassium solution that requires extreme caution in preparation and administration, according to the American Academy of Pediatrics 7
  • The conversion is based on the molecular weight and valence of potassium chloride, resulting in a calculation of 150 mg ÷ 74.5 mg/mEq = 2.01 mEq/mL (rounded to 2 mEq/mL), as recommended by the American Academy of Pediatrics 7

Critical Safety Considerations for Pediatric Use

  • For pediatric use, particularly in an 18-month-old child with severe hypokalemia, this concentration is dangerously high and must be diluted before administration, as stated by the American Academy of Pediatrics 7
  • This solution is 50 times more concentrated than the maximum safe peripheral concentration, highlighting the need for careful handling and administration, according to the American Academy of Pediatrics 7